Complementary roles of grey matter MTR and T2 lesions in predicting progression in early PPMS

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 82, Issue 4, 2011, Pages 423-428

  Tur, C ^a,b   Khaleeli, Z ^a   Ciccarelli, O ^a   Altmann, D R ^a,c   Cercignani, M ^a,d   Miller, D H ^a   Thompson, Alan J ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d IRCCS FONDAZIONE SANTA LUCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID DERIVATIVE; MITOXANTRONE; STEROID;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; DIFFUSION WEIGHTED IMAGING; DISEASE COURSE; EARLY DIAGNOSIS; EXPANDED DISABILITY STATUS SCALE; FEMALE; GRAY MATTER; HOLE PEG TEST; HUMAN; MAGNETIC STIMULATION; MAGNETISATION TRANSFER RATIO; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PACED AUDITORY SERIAL ADDITION TEST; PREDICTION; PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS; PRIORITY JOURNAL; TIMED WALK TEST; WHITE MATTER;

ADULT; ATROPHY; BRAIN MAPPING; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; NERVE FIBERS, MYELINATED; NERVE FIBERS, UNMYELINATED; PROGNOSIS; SEVERITY OF ILLNESS INDEX;

EID: 79952738608     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2010.209890     Document Type: Article

References (40)

1. Tremlett H, Paty D, Devonshire V. The natural history of primary progressive MS in British Columbia, Canada. Neurology 2005;65:1919-23. (Pubitemid 43970111)
2. Sastre-Garriga J, Ingle GT, Rovaris M, et al. Long-term clinical outcome of primary progressive MS: predictive value of clinical and MRI data. Neurology 2005;65:633-5. (Pubitemid 41170733)
3. Khaleeli Z, Ciccarelli O, Manfredonia F, et al. Predicting progression in primary progressive multiple sclerosis: a 10-year multicenter study. Ann Neurol 2008;63:790-3. (Pubitemid 351945538)
4. Schmierer K, Scaravilli F, Altmann DR, et al. Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain. Ann Neurol 2004;56:407-15. (Pubitemid 39166560)
5. Khaleeli Z, Sastre-Garriga J, Ciccarelli O, et al. Magnetisation transfer ratio in the normal appearing white matter predicts progression of disability over 1 year in early primary progressive multiple sclerosis. J Neurol Neurosurg Psychiatry 2007;78:1076-82.
6. Khaleeli Z, Altmann DR, Cercignani M, et al. Magnetization transfer ratio in gray matter: a potential surrogate marker for progression in early primary progressive multiple sclerosis. Arch Neurol 2008;65:1454-9.
7. + ATPase in chronic multiple sclerosis lesions. Ann Neurol 2008;63:428-35.
8. Peterson JW, Bo L, Mork S, et al. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol 2001;50:389-400. (Pubitemid 32848742)
9. Geurts JJ, Barkhof F. Grey matter pathology in multiple sclerosis. Lancet Neurol 2008;7:841-51.
10. Calabrese M, Agosta F, Rinaldi F, et al. Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis. Arch Neurol 2009;66:1144-50.
11. Roosendaal SD, Moraal B, Pouwels PJ, et al. Accumulation of cortical lesions in MS: relation with cognitive impairment. Mult Scler 2009;15:708-14.
12. Bakshi R, Neema M, Healy BC, et al. Predicting clinical progression in multiple sclerosis with the magnetic resonance disease severity scale. Arch Neurol 2008;65:1449-53.
13. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-52. (Pubitemid 14237132)
14. Hobart J, Freeman J, Thompson A. Kurtzke scales revisited: the application of psychometric methods to clinical intuition. Brain 2000;123:1027-40.
15. Bosma LV, Kragt JJ, Brieva L, et al. The search for responsive clinical endpoints in primary progressive multiple sclerosis. Mult Scler 2009;15:715-20.
16. Cutter GR, Baier ML, Rudick RA, et al. Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain 1999;122:871-82. (Pubitemid 29219261)
17. Thompson AJ, Montalban X, Barkhof F, et al. Diagnostic criteria for primary progressive multiple sclerosis: a position paper. Ann Neurol 2000;47:831-5. (Pubitemid 30390209)
18. Lechner-Scott J, Kappos L, Hofman M, et al. Can the Expanded Disability Status Scale be assessed by telephone? Mult Scler 2003;9:154-9.
19. Barker GJ, Tofts PS, Gass A. An interleaved sequence for accurate and reproducible clinical measurement of magnetization transfer ratio. Magn Reson Imaging 1996;14:403-11. (Pubitemid 26195923)
20. Plummer DL. DispImage: Un mezzo di analisi e presentazione per iconografia medica [DispImage: a display and analysis tool for medical images]. Riv Neuroradiol 1992;5:1715-20.
21. Smith SM, Jenkinson M, Johansen-Berg H, et al. Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. Neuroimage 2006;31:1487-505.
22. Hoogervorst EL, Kalkers NF, Uitdehaag BM, et al. A study validating changes in the multiple sclerosis functional composite. Arch Neurol 2002;59:113-16. (Pubitemid 34052563)
23. Fischer JS, Jak AJ, Kniker JE, et al. Administration and scoring manual for the MS Functional Composite measure (MSFC). National Multiple Sclerosis Society, ed. 2nd edn (2001). US: UNITECH Communications, 1999.
24. Verbeke G, Molenberghs G. Linear Mixed Models for Longitudinal Data. Springer-Verlag New York Inc, New York, 2000.
25. Laird NM, Ware JH. Random-effects models for longitudinal data. Biometrics 1982;38:963-74.
26. Fisniku LK, Brex PA, Altmann DR, et al. Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis. Brain 2008;131:808-17. (Pubitemid 351294716)
27. Geurts JJ, Pouwels PJ, Uitdehaag BM, et al. Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging. Radiology 2005;236:254-60. (Pubitemid 40853320)
28. Barkhof F, Calabresi PA, Miller DH, et al. Imaging outcomes for neuroprotection and repair in multiple sclerosis trials. Nat Rev Neurol 2009;5:256-66.
29. Sepulcre J, Sastre-Garriga J, Cercignani M, et al. Regional gray matter atrophy in early primary progressive multiple sclerosis: a voxel-based morphometry study. Arch Neurol 2006;63:1175-80. (Pubitemid 44232328)
30. Khaleeli Z, Cercignani M, Audoin B, et al. Localized grey matter damage in early primary progressive multiple sclerosis contributes to disability. Neuroimage 2007;37:253-61. (Pubitemid 47068988)
31. Rovaris M, Judica E, Gallo A, et al. Grey matter damage predicts the evolution of primary progressive multiple sclerosis at 5 years. Brain 2006;129:2628-34. (Pubitemid 44522096)
32. Davies GR, Altmann DR, Hadjiprocopis A, et al. Increasing normal-appearing grey and white matter magnetisation transfer ratio abnormality in early relapsing-remitting multiple sclerosis. J Neurol 2005;252:1037-44. (Pubitemid 41355832)
33. Rovaris M, Judica E, Sastre-Garriga J, et al. Large-scale, multicentre, quantitative MRI study of brain and cord damage in primary progressive multiple sclerosis. Mult Scler 2008;14:455-64. (Pubitemid 351943857)
34. Camp SJ, Stevenson VL, Thompson AJ, et al. A longitudinal study of cognition in primary progressive multiple sclerosis. Brain 2005;128:2891-8. (Pubitemid 41746642)
35. Ukkonen M, Vahvelainen T, Hamalainen P, et al. Cognitive dysfunction in primary progressive multiple sclerosis: a neuropsychological and MRI study. Mult Scler 2009;15:1055-61.
36. Ramio-Torrenta L, Sastre-Garriga J, Ingle GT, et al. Abnormalities in normal appearing tissues in early primary progressive multiple sclerosis and their relation to disability: a tissue specific magnetisation transfer study. J Neurol Neurosurg Psychiatry 2006;77:40-5. (Pubitemid 43022688)
37. Perneger TV. What's wrong with Bonferroni adjustments. BMJ 1998;316:1236-8. (Pubitemid 28171344)
38. Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiology 1990;1:43-6. (Pubitemid 20255621)
39. Oppenheimer DR. The cervical cord in multiple sclerosis. Neuropathol Appl Neurobiol 1978;4:151-62. (Pubitemid 8317203)
40. Stevenson VL, Leary SM, Losseff NA, et al. Spinal cord atrophy and disability in MS: a longitudinal study. Neurology 1998;51:234-8. (Pubitemid 28345389)